CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells

Molecular Oncology

Volumn 6, Issue 1, 2012, Pages 48-61

  Fu, Yuan Shan ^a   Wang, Qian ^a   Ma, Jing Xin ^a   Yang, Xiang Hong ^b   Wu, Mo Li ^a   Zhang, Kai Li ^a   Kong, Qing You ^a   Chen, Xiao Yan ^a   Sun, Yuan ^a   Chen, Nan Nan ^a   Shu, Xiao Hong ^a   Li, Hong ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CRABP II; DNA methylation; Epigenetic modulation: Gene transfection; Medulloblastoma; RA signaling; Retinoic acid

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA TUBULIN; BISULFITE; CRABP I PROTEIN; CRABP II PROTEIN; PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; SMALL INTERFERING RNA; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; TISSUE MICROARRAY; UPREGULATION;

EID: 84856304032     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.11.004     Document Type: Article

References (47)

1. Abu-Abed S., MacLean G., Fraulob V., Chambon P., Petkovich M., Dollé P. Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech. Dev. 2002, 110:173-177.
2. Aström A., Tavakkol A., Pettersson U., Cromie M., Elder J.T., Voorhees J.J. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin invivo and in skin fibroblasts invitro. J. Biol. Chem. 1991, 266:17662-17666.
3. Bergamaschi D., Gasco M., Hiller L., Sullivan A., Syed N., Trigiante G., Yulug I., Merlano M., Numico G., Comino A., Attard M., Reelfs O. P53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell. 2003, 3:387-402.
4. Budhu A.S., Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell Biol. 2002, 22:2632-2641.
5. Calmon M.F., Rodrigues R.V., Kaneto C.M., Moura R.P., Silva S.D., Mota L.D., Pinheiro D.G., Torres C., de Carvalho A.F., Cury P.M., Nunes F.D., Nishimoto I.N. Epigenetic silencing of CRABP2 and MX1 in Head and Neck tumors. Neoplasia 2009, 11:1329-1339.
6. Chang Q., Chen Z., You J., McNutt M.A., Zhang T., Han Z., Zhang X., Gong E., Gu J. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line. J. Neurooncol. 2007, 84:263-267.
7. Chatty E.M., Earle K.M. Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 1971, 28:977-983.
8. Corlazzoli F., Rossetti S., Bistulfi G., Ren M., Sacchi N. Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network. PLoS One 2009, 4:e4305.
9. Delva L., Bastie J.N., Rochette-Egly C., Kraïba R., Balitrand N., Despouy G., Chambon P., Chomienne C. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol. Cell Biol. 1999, 19:7158-7167.
10. Dong D., Ruuska S.E., Levinthal D.J., Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 1999, 274:23695-23698.
11. Eberhart C.G., Kepner J.L., Goldthwaite P.T., Kun L.E., Duffner P.K., Friedman H.S., Strother D.R., Burger P.C. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002, 94:552-560.
12. Fossati P., Ricardi U., Orecchia R. Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat. Rev. 2009, 35:79-96.
13. Freemantle S.J., Spinella M.J., Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003, 22:7305-7315.
14. Gumireddy K., Sutton L.N., Phillips P.C., Reddy C.D. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin. Cancer Res. 2003, 9:4052-4059.
15. Gururangan S., Krauser J., Watral M.A., Driscoll T., Larrier N., Reardon D.A., Rich J.N., Quinn J.A., Vredenburgh J.J., Desjardins A., McLendon R.E., Fuchs H. Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. Neuro Oncol. 2008, 10:745-751.
16. Gupta A., Kessler P., Rawwas J., Williams B.R. Regulation of CRABP-II expression by MycN in Wilms tumor. Exp. Cell Res. 2008, 314:3663-3668.
17. Hallahan A.R., Pritchard J.I., Chandraratna R.A., Ellenbogen R.G., Geyer J.R., Overland R.P., Strand A.D., Tapscott S.J., Olson J.M. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat. Med. 2003, 9:1033-1038.
18. Ho D.M., Hsu C.Y., Wong T.T., Ting L.T., Chiang H. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol. 2000, 99:482-488.
19. Kawashima M., Suzuki S.O., Doh-ura K., Iwaki T. alpha-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation. Acta Neuropathol. 2000, 99:154-160.
20. Keles G.E., Berger M.S., Srinivasan J., Kolstoe D.D., Bobola M.S., Silber J.R. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol. Res. 1995, 7:493-503.
21. Kido M., Ueno M., Onodera M., Matsumoto K., Imai T., Haba R., Tamiya T., Huang C.L., Sakamoto H. Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin. Pathol. Int. 2009, 59:255-260.
22. Kitamura K., Kiyoi H., Yoshida H., Tobita T., Takeshita A., Ohno R., Naoe T. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation. Cancer Chemother. Pharmacol. 2004, 40:36S-41S.
23. Liu J., Guo L., Li J.W., Liu N., Li H. All-trans retinoic acid modulates fas expression and enhances chemosensitivity of human medulloblastoma cells. Int. J. Mol. Med. 2000, 5:145-149.
24. Lusher M.E., Lindsey J.C., Latif F., Pearson A.D., Ellison D.W., Clifford S.C. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res. 2002, 62:5906-5911.
25. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W., Huelsken J. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 2008, 452:650-653.
26. Matsumoto M. Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines. Nippon Geka Hokan 1991, 60:113-121.
27. Meyskens F.L., Manetta A. Prevention of cervical intraepithelial neoplasia and cancer. Am. J. Clin. Nutr. 1995, 62:1417S-1419S.
28. Mueller S., Chang S. Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics 2009, 6:570-586.
29. Niederreither K., Abu-Abed S., Schuhbaur B., Petkovich M., Chambon P., Dollé P. Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat. Genet. 2002, 31:84-88.
30. Ohta M., Taga T., Nomura A., Kato H., Takano T., Maruo Y., Takeuchi Y., Ishida M., Ohta S. Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma. J. Med. Virol. 2011, 83:1582-1584.
31. Osanai M., Sawada N., Lee G.H. Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1. Oncogene 2010, 29:1135-1144.
32. Pfister S.M., Korshunov A., Kool M., Hasselblatt M., Eberhart C., Taylor M.D. Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol. 2010, 120:553-566.
33. Ravandi F. Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy. Leuk. Lymphoma 2009, 50:1073-1074.
34. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129:723-733.
35. Schug T.T., Berry D.C., Toshkov I.A., Cheng L., Nikitin A.Y., Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc. Natl. Acad. Sci. USA 2008, 105:7546-7551.
36. Sessler R.J., Noy N. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol. Cell. 2005, 18:343-353.
37. Tanaka K., Imoto I., Inoue J., Kozaki K., Tsuda H., Shimada Y., Aiko S., Yoshizumi Y., Iwai T., Kawano T., Inazawa J. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007, 26:6456-6468.
38. Tang X.H., Vivero M., Gudas L.J. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp. Cell Res. 2008, 314:38-51.
39. Uhrig M., Brechlin P., Jahn O., Knyazev Y., Weninger A., Busia L., Honarnejad K., Otto M., Hartmann T. Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential. BMC Med. 2008, 6:38.
40. van der Burg B., van der Leede B.M., Kwakkenbos-Isbrücker L., Salverda S., de Laat S.W., van der Saag P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell Endocrinol. 1993, 91:149-157.
41. Wang Q., Li H., Liu N., Chen X.Y., Wu M.L., Zhang K.L., Kong Q.Y., Liu J. Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells. Neurosci. Lett. 2008, 438:168-173.
42. Warrell R.P., de Thé H., Wang Z.Y., Degos L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993, 329:177-189.
43. Wei L.N., Lee C.H. Demethylation in the 5'-flanking region of mouse cellular retinoic acid binding protein-I gene is associated with its high level of expression in mouse embryos and facilitates its induction by retinoic acid in P19 embryonal carcinoma cells. Dev. Dyn. 1994, 201:1-10.
44. White R.J., Nie Q., Lander A.D., Schilling T.F. Complex regulation of cyp26a1 Creates a Robust retinoic acid gradient in the Zebrafish Embryo. PLoS Biol. 2007, 5:e304.
45. Zhang K.L., Sun Y., Li Y., Liu M., Qu B., Cui S.H., Kong Q.Y., Chen X.Y., Li H., Liu J. Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of China. Transl Oncol. 2008, 1:28-35.
46. Zhu G.H., Huang J., Bi Y., Su Y., Tang Y., He B.C., He Y., Luo J., Wang Y., Chen L., Zuo G.W., Jiang W., Luo Q., Shen J., Liu B., Zhang W.L., Shi Q., Zhang B.Q., Kang Q., Zhu J., Tian J., Luu H.H., Haydon R.C., Chen Y., He T.C. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 2009, 78:195-204.
47. Zusi F.C., Lorenzi M.V., Vivat-Hannah V. Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discov. Today 2002, 7:1165-1174.